Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1057-1065

  Hahn, C S ^a   French, O G ^a   Foley, P ^a   Martin, E N ^a   Taylor, R P ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT E; GLYCOPROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; ERYTHROCYTE; MONKEY; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS TITRATION;

EID: 0035863785     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1057     Document Type: Article

References (65)

1. Pathogenesis of dengue: Challenges to molecular biology
2. Dengue: The risk to developed and developing countries
3. Dengue/dengue hemorrhagic fever: The emergence of a global health problem
4. Dengue and dengue hemorrhagic fever
5. Immunological enhancement of dengue virus replication
6. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
7. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody
8. Review of the factors modulating dengue transmission
9. Global distribution and continuing spread of Aedes albopictus
10. Imported vector- and rodent-borne virus infections: An introduction
11. Pathogenesis of dengue virus diseases: Missing pieces in the jigsaw
12. Dengue virus infection: Epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention
13. Dengue reemergence in Argentina
14. Infectious diseases in Latin America and the Caribbean: Are they really emerging and increasing?
15. The first major outbreak of dengue hemorrhagic fever in Delhi, India
16. Reemergence of dengue in Cuba: A 1997 epidemic in Santiago de Cuba
17. Emerging infectious diseases: Southeast Asia
18. Dengue surveillance in Florida, 1997-98
19. Texas Records Dengue Fever Death
20. Dengun viremia titer, antibody response pattern, and virus serotype correlate with disease severity
21. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model
22. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model
23. The primate erythrocyte complement receptor (CR1) as a privileged site: Binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis
24. Primate erythrocyte (E) complement receptor (CRl) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation
25. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver it a mouse model
26. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies
27. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence
28. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies
29. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome
30. Antigen-based heteropolymers: A potential therapy for binding and clearing autoantibodies via erythrocyte CR1
31. In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocytc complement receptor
32. Dengue-2 vaccine: Preparation from a small-plaque virus clone
33. Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses
34. Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses
35. Clearance of bloodborne pathogens mediated through bispecific monoclonal antibodies bound to the primate erythrocyte complement receptor
36. Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen
37. Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice
38. Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor
39. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells
40. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys
41. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation
42. Peripheral catabolism of CR1 the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE)
43. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters or isolated human erythrocytes
44. Experimental infection of monkeys with Langat virus. II. Turnover of circulating virus
45. Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques
46. Rift Valley Fever virus in mice. I. General feature of the infection
47. Rift Valley Fever virus in mice. III. Further quantitative features of the infectious process
48. Rift Valley Fever virus in mice. II. Adsorption and multiplication of virus
49. The response of mice to large intravenous injections of ectromelia virus. I. The fate of injected virus
50. Blood clearance of P-32 labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice
51. Regulation of antibody responses: The role of complement and adhesion molecules
52. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade
53. Dengue virus and endothelial cell: A related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever
54. Dengue viruses induce cell proliferation and morphological changes of endothelial cells
55. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
56. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis
57. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
58. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages
59. Structural polymorphism of the human monocyte 40 kilodalton Fc receptor for IgG
60. Fcγ receptor III on human neutrophils: Allelic variants have functionally distinct capacities
61. Genetic diversity in human Fc receptor II for immunoglobulin G: Fcγ receptor IIA ligand-binding polymorphism
62. Clinical relevance of Fcγ receptor potymorphisms
63. IgG receptor polymorphisms: Risk factors for disease